Browsed by
Tag: FDA drugs for ms

Ocrevus infusion scheduled for August 7

Ocrevus infusion scheduled for August 7

Sure, it is scheduled, but the approval isn’t there. I received a call the other day from the insurance company that the expedited review has been denied. So I called the insurance company. I was told that the infusion was still under review. Under review for what??? When I tried to get Rituxan approved, the denial was because Rituxan wasn’t a FDA approved drug for multiple sclerosis. The denial letter went on to tell me based on my history that…

Read More Read More

Verified by MonsterInsights